Special Issue "Shaping Medicinal Chemistry for the New Decade"
Deadline for manuscript submissions: 31 December 2022 | Viewed by 243
Interests: multitarget anti-Alzheimer agents; hybrid compounds; cholinesterase inhibitors; amyloid anti-aggregating compounds; BACE-1 inhibitors; antiprotozoan compounds
Special Issues, Collections and Topics in MDPI journals
Special Issue in Molecules: Multicomponent Reaction-Based Synthesis of Bioactive Molecules
Special Issue in Molecules: Emerging Drug Discovery Approaches against Infectious Diseases
Special Issue in Molecules: Present and Future of Medicinal Chemistry Research: A Young Researchers’ Perspective
Special Issue in Molecules: Molecules against Alzheimer II
Special Issue in Molecules: Facing Novel Challenges in Drug Discovery
Topical Collection in Molecules: Breakthroughs in Medicinal Chemistry: New Targets and Mechanisms, New Drugs, New Hopes
Special Issue in Molecules: Breakthroughs in Medicinal Chemistry: New Targets and Mechanisms, New Drugs, New Hopes 2020
Special Issue in Molecules: Feature Papers to Celebrate Molecules Reaches 20,000 Articles Milestone
Special Issue in Molecules: 25th Anniversary of Molecules—Recent Advances in Medicinal Chemistry
Special Issue in Molecules: Molecules Medicinal Chemistry Reviews
Special Issue in Molecules: Featured Papers in Medicinal Chemistry
Special Issue in Molecules: Molecules in 2022
Special Issue in Molecules: Exclusive Papers from the Editorial Board Members (EBMs) of the Section “Medicinal Chemistry” of Molecules
Special Issue in Molecules: Featured Papers in Medicinal Chemistry II
Interests: drug design; medicinal chemistry; machine learning for drug design; extraction of natural compounds; essential oils
Special Issues, Collections and Topics in MDPI journals
Topical Collection in Molecules: Molecular Docking
Special Issue in Molecules: Modulators of Histone Acetylation: A Medicinal Chemistry Perspective
Special Issue in Molecules: Modulators of Histone Methylation: A Medicinal Chemistry Perspective
Special Issue in Molecules: Application of Computational Methods in Drug Design
Special Issue in Applied Sciences: Essential Oils: Potential Effects on the Cardiovascular System
Special Issue in Molecules: Chemoinformatics in Drug Design: Achievements and Challenges
Special Issue in Plants: Essential Oils Extraction Methods, Chemistry and Bioactivities: New Insights and Findings
Special Issue in Molecules: Trends and Prospects in Computer-Aided Drug Design
Medicinal chemistry must be continuously shaped to confront changing therapeutic challenges, to adapt to emerging novel drug modalities, and to take advantage of new technologies with high potential to speed up drug discovery.
This Special Issue is related to the Third Molecules Medicinal Chemistry Symposium—Shaping Medicinal Chemistry for the New Decade (MMCS2022), which will be held in Rome (Italy) on July 27–29, 2022. At the Symposium, current challenges in the drug discovery field will be discussed while reporting novel and revisited drug discovery approaches against particularly challenging diseases, and medicinal chemistry stories about recently implemented projects in target and hit identification, hit-to-lead optimization, tuning of physicochemical and pharmacokinetic properties, preclinical and clinical development, etc.
Participants of the Symposium and all researchers working in the field are cordially invited to contribute original research articles, short communications, or reviews to this Special Issue of Molecules, reporting on recent innovative medicinal-chemistry projects, particularly (but not exclusively) regarding the design and development of novel drug candidates against drug-resistant microorganisms and SARS-CoV-2, different modalities of targeting protein degradation with therapeutic purposes, the use of machine learning in drug design, the use of natural products in drug discovery, and the rational design and profiling of multitarget agents to tackle multifactorial diseases. Participants of this conference are encouraged to contribute with a full manuscript to our Special Issue related to the conference in the journal Molecules. The conference participants will be granted a 30% discount on the publishing fees. For planned manuscripts, a title and short abstract (about 100 words) should be sent to the Editorial Office for announcement on this website.
Dr. Diego Muñoz-Torrero
Dr. Rino Ragno
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Molecules is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2300 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- drug discovery
- drug design
- drug synthesis
- anti-infective agents
- targeted protein degraders
- multitarget drugs
- machine learning
- natural products
- novel drugs